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Abstract. Chagas disease (CD) is an important parasitic disease and recent estimates indicate that 
6-7 million people are chronically infected by T. cruzi, mostly in Latin America. Development of a 
sensitive, label free electrochemical immunosensor for the qualitative detection of anti- Trypanosoma 
cruzi antibodies (i.e.CD) in serum samples is described. A multilayered ultra-thin film consisting of 
cationic nanohybrid gold nanoparticles stabilized by 3-n-propylpyridinium silsesquioxane chloride 
(AuNPs-SiPy) and sodium poly(vinylsulfonate) (PVS) was deposited using the Layer-by-Layer (LbL) 
technique. Sensitized erythrocytes with T. cruzi antigens were immobilized in the (AuNPSiPVS)4 LbL 
film, in which the biological reaction to detect anti-T. cruzi immunoglobulins was detected by 
electrochemical impedance spectroscopy. Each step of electrode modification and analytical performance 
of the immunosensors was characterized by the variation in charge transfer resistance values and thus the 
immunosensor was optimized through a fractional factorial design. The immunosensor showed good 
selectivity when incubated in a negative control sample and in a serum sample containing anti-
Toxoplasma gondii antibodies, indicating potential for the qualitative detection of anti-T. cruzi antibodies 
in clinical diagnosis. 
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